Type I hypersensitivity

Revision as of 17:10, 20 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Type I hypersensitivity
MeSH D006969

WikiDoc Resources for Type I hypersensitivity

Articles

Most recent articles on Type I hypersensitivity

Most cited articles on Type I hypersensitivity

Review articles on Type I hypersensitivity

Articles on Type I hypersensitivity in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Type I hypersensitivity

Images of Type I hypersensitivity

Photos of Type I hypersensitivity

Podcasts & MP3s on Type I hypersensitivity

Videos on Type I hypersensitivity

Evidence Based Medicine

Cochrane Collaboration on Type I hypersensitivity

Bandolier on Type I hypersensitivity

TRIP on Type I hypersensitivity

Clinical Trials

Ongoing Trials on Type I hypersensitivity at Clinical Trials.gov

Trial results on Type I hypersensitivity

Clinical Trials on Type I hypersensitivity at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Type I hypersensitivity

NICE Guidance on Type I hypersensitivity

NHS PRODIGY Guidance

FDA on Type I hypersensitivity

CDC on Type I hypersensitivity

Books

Books on Type I hypersensitivity

News

Type I hypersensitivity in the news

Be alerted to news on Type I hypersensitivity

News trends on Type I hypersensitivity

Commentary

Blogs on Type I hypersensitivity

Definitions

Definitions of Type I hypersensitivity

Patient Resources / Community

Patient resources on Type I hypersensitivity

Discussion groups on Type I hypersensitivity

Patient Handouts on Type I hypersensitivity

Directions to Hospitals Treating Type I hypersensitivity

Risk calculators and risk factors for Type I hypersensitivity

Healthcare Provider Resources

Symptoms of Type I hypersensitivity

Causes & Risk Factors for Type I hypersensitivity

Diagnostic studies for Type I hypersensitivity

Treatment of Type I hypersensitivity

Continuing Medical Education (CME)

CME Programs on Type I hypersensitivity

International

Type I hypersensitivity en Espanol

Type I hypersensitivity en Francais

Business

Type I hypersensitivity in the Marketplace

Patents on Type I hypersensitivity

Experimental / Informatics

List of terms related to Type I hypersensitivity

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Type I hypersensitivity (or immediate hypersensitivity) is an allergic reaction provoked by reexposure to a specific type of antigen referred to as an allergen.[1] Exposure may be by ingestion, inhalation, injection, or direct contact. The difference between a normal immune response and a type I hypersensitive response is that plasma cells secrete IgE. This class of antibodies binds to Fc receptors on the surface of tissue mast cells and blood basophils. Mast cells and basophils coated by IgE are "sensitized." Later exposure to the same allergen, cross-links the bound IgE on sensitized cells resulting in degranulation and the secretion of pharmacologically active mediators such as histamine, leukotriene, and prostaglandin that act on the surrounding tissues. The principal effects of these products are vasodilation and smooth-muscle contraction.

The reaction may be either local or systemic. Symptoms vary from mild irritation to sudden death from anaphylactic shock. Treatment usually involves epinephrine, antihistamines, and corticosteroids. If the entire body gets involved, then anaphylaxis can take place; an acute, systemic reaction that can prove fatal.

Examples

Some examples:

References


Template:Hypersensitivity and autoimmune diseases



Template:WikiDoc Sources